Khan SR (2014) Reactive oxygen species, inflammation and calcium oxalate nephrolithiasis. Transl Androl Urol 3:256–276
PubMed PubMed Central Google Scholar
Khan SR, Canales BK, Dominguez-Gutierrez PR (2021) Randall’s plaque and calcium oxalate stone formation: role for immunity and inflammation. Nat Rev Nephrol 17:417–433
Article CAS PubMed Google Scholar
Dejban P, Wilson E, Jayachandran M, Herrera Hernandez L, Haskic Z, Wellik L, Sinha S, Rule A, Denic A, Koo K, Potretzke A, Lieske J (2022) Inflammatory cells in Nephrectomy tissue from patients without and with a history of urinary Stone Disease. Clin J Am Soc Nephrol 17:414–422
Article CAS PubMed PubMed Central Google Scholar
Capolongo G, Ferraro M, Unwin R (2023) Inflammation and kidney stones: cause and effect? Curr Opin Urol 33:129–135
Pepys MB, Hirschfield GM (2003) C-reactive protein: a critical update. J Clin Invest 111:1805–1812
Article CAS PubMed PubMed Central Google Scholar
Shoag J, Eisner BH (2014) Relationship between C-reactive protein and kidney stone prevalence. J Urol 191:372–375
Article CAS PubMed Google Scholar
Oda E (2014) Overweight and high-sensitivity C-reactive protein are weakly associated with kidney stone formation in Japanese men. Int J Urol 21:1005–1011
Article CAS PubMed Google Scholar
Hasna A, Meiyappan K, Periyasam SG, Kalyaperumal M, Bobby Z, Subramaniam AV (2015) Is urolithiasis associated with increased levels of high sensitivity C-reactive protein and interleukin-6 in diabetic patients? J Clin Diagn Res 9:Bc01–03
PubMed PubMed Central Google Scholar
Lovegrove CE, Bešević J, Wiberg A, Lacey B, Littlejohns TJ, Allen NE, Goldsworthy M, Kim J, Hannan FM, Curhan GC, Turney BW, McCarthy MI, Mahajan A, Thakker RV, Holmes MV, Furniss D, Howles SA (2023) Central Adiposity increases risk of kidney Stone Disease through effects on serum calcium concentrations. J Am Soc Nephrol 34:1991–2011
Article PubMed PubMed Central Google Scholar
Taguchi K, Okada A, Hamamoto S, Unno R, Moritoki Y, Ando R, Mizuno K, Tozawa K, Kohri K, Yasui T (2016) M1/M2-macrophage phenotypes regulate renal calcium oxalate crystal development. Sci Rep 6:35167
Article CAS PubMed PubMed Central Google Scholar
Taguchi K, Hamamoto S, Okada A, Unno R, Kamisawa H, Naiki T, Ando R, Mizuno K, Kawai N, Tozawa K, Kohri K, Yasui T (2017) Genome-wide gene expression profiling of Randall’s plaques in Calcium Oxalate Stone formers. J Am Soc Nephrol 28:333–347
Article CAS PubMed Google Scholar
Williams J, Holmes RP, Assimos DG, Mitchell T (2016) Monocyte mitochondrial function in Calcium Oxalate Stone formers. Urology 93:224e221–224e226
Makki MS, Winfree S, Lingeman JE, Witzmann FA, Worcester EM, Krambeck AE, Coe FL, Evan AP, Bledsoe S, Bergsland KJ, Khochare S, Barwinska D, Williams JC Jr., El-Achkar TM (2020) A precision medicine approach uncovers a unique signature of neutrophils in patients with brushite kidney stones. Kidney Int Rep 5:663–677
Article PubMed PubMed Central Google Scholar
Canela VH, Bowen WS, Ferreira RM, Lingeman JE, Sabo AR, Barwinska D, Winfree S, Lake B, Cheng Y-H, LaFavers KA, Zhang K, Coe FL, Worcester E, Jain S, Eadon MT, James C, Williams J, El-Achkar TM (2023) A spatially anchored transcriptomic atlas of the human kidney papilla identifies significant immune injury and matrix remodeling in patients with stone disease. Nat Commun 14:4140
Article CAS PubMed PubMed Central Google Scholar
Coe FL, Evan AP, Lingeman JE, Worcester EM (2010) Plaque and deposits in nine human stone diseases. Urol Res 38:239–247
Article PubMed PubMed Central Google Scholar
Randall A (1937) The origin and growth of renal calculi. Ann Surg 105:1009–1027
Article CAS PubMed PubMed Central Google Scholar
Randall A (1940) Papillary pathology as a precursor of primary renal calculus. J Urol 44:580–589
Letavernier E, Vandermeersch S, Traxer O, Tligui M, Baud L, Ronco P, Haymann JP, Daudon M (2015) Demographics and characterization of 10,282 Randall plaque-related kidney stones: a new epidemic? Med (Baltim) 94:e566
Williams JC, Al-Awadi H, Muthenini M, Bledsoe SB, El-Achkar T, Evan AP, Coe F, Lingeman JE, Worcester EM (2022) Stone morphology distinguishes two pathways of idiopathic calcium oxalate stone pathogenesis. J Endourol 36:694–702
Article PubMed PubMed Central Google Scholar
Williams JC Jr., Bowen WS, Lingeman JE, Rivera M, Worcester EM, El-Achkar TM (2024) Two distinct phenotypes of calcium oxalate stone formers could imply different long-term risks for renal function. Urolithiasis 52:133
Borofsky MS, Paonessa JE, Evan AP, Williams JC Jr., Coe FL, Worcester EM, Lingeman JE (2016) A proposed Grading System to standardize the description of renal papillary appearance at the Time of Endoscopy in patients with Nephrolithiasis. J Endourol 30:122–127
Article PubMed PubMed Central Google Scholar
Borofsky MS, Williams JC Jr., Dauw CA, Cohen A, Evan AP, Coe FL, Worcester E, Lingeman JE (2019) Association between Randall’s Plaque Stone anchors and renal papillary pits. J Endourol 33:337–342
Article PubMed PubMed Central Google Scholar
Evan AP, Lingeman JE, Coe FL, Shao Y, Parks JH, Bledsoe SB, Phillips CL, Bonsib S, Worcester EM, Sommer AJ, Kim SC, Tinmouth WW, Grynpas M (2005) Crystal-associated nephropathy in patients with brushite nephrolithiasis. Kidney Int 67:576–591
Article CAS PubMed Google Scholar
Iványi B, Olsen S (1995) Tubulitis in Renal Disease. In: Dodd SM (ed) Tubulointerstitial and cystic disease of the kidney. Springer Berlin Heidelberg, Berlin, Heidelberg, pp 117–143
Borofsky MS, Handa RK, Evan AP, Williams JC Jr., Bledsoe S, Coe FL, Worcester EM, Lingeman JE (2020) In vivo renal tubule pH in stone-forming human kidneys. J Endourol 34:203–208
Article PubMed PubMed Central Google Scholar
Evan AP, Lingeman JE, Worcester EM, Sommer AJ, Phillips CL, Williams JC Jr., Coe FL (2014) Contrasting histopathology and crystal deposits in kidneys of idiopathic stone formers who produce hydroxyapatite, brushite, or calcium oxalate stones. Anat Rec 297:731–748
Worcester EM, Evan AP, Coe FL, Lingeman JE, Krambeck A, Sommers A, Phillips CL, Milliner D (2013) A test of the hypothesis that oxalate secretion produces proximal tubule crystallization in primary hyperoxaluria type I. Am J Physiol - Ren Physiol 305:F1574–F1584
Thamilselvan S, Khan SR (1998) Oxalate and calcium oxalate crystals are injurious to renal epithelial cells: results of in vivo and in vitro studies. J Nephrol 11(Suppl 1):66–69
Sun XY, Gan QZ, Ouyang JM (2015) Calcium oxalate toxicity in renal epithelial cells: the mediation of crystal size on cell death mode. Cell Death Discovery 1:15055
Article CAS PubMed PubMed Central Google Scholar
Letavernier E, Kauffenstein G, Huguet L, Navasiolava N, Bouderlique E, Tang E, Delaitre L, Bazin D, de Frutos M, Gay C, Perez J, Verpont M-C, Haymann J-P, Pomozi V, Zoll J, Le Saux O, Daudon M, Leftheriotis G, Martin L (2018) ABCC6 Deficiency Promotes Development of Randall Plaque. J Am Soc Nephrol 29:2337–2347
Article CAS PubMed PubMed Central Google Scholar
Curry JN, Saurette M, Askari M, Pei L, Filla MB, Beggs MR, Rowe PSN, Fields T, Sommer AJ, Tanikawa C, Kamatani Y, Evan AP, Totonchi M, Alexander RT, Matsuda K, Yu ASL (2020) Claudin-2 deficiency associates with hypercalciuria in mice and human kidney stone disease. J Clin Investig 130
Klahr S, Morrissey J (2002) Obstructive nephropathy and renal fibrosis. Am J Physiol Ren Physiol 283:F861–875
Comments (0)